SciDoc Publishers | Open Access | Science Journals | Media Partners


International Journal of Dentistry and Oral Science (IJDOS)  /  IJDOS-2377-8075-08-10013

A Review On The Guidelines For Nutritional Assessment for HNC (Head and Neck Cancer) Patients Managed By Surgery


Shrikanth Muralidharan1*, Arunkumar Acharya2, Pramila M3, Shanthi Margabandhu4, Seema Kamble5

1 Reader, Department of Public Health Dentistry, Madha Dental College and Hospital, West Tambaram, Chennai, India.
2 Professor and Head, Department of Public Health Dentistry, Navodaya Dental College and Hospital, Raichur, India.
3 Professor and Head, Department of Public Health Dentistry, MR Ambedkar Dental College and Hospital, Bangalore, Karnataka, India.
4 Public Health Dentist, Private Practitioner, Bangalore, Karnataka, India.
5 Associate Professor, Department of Public Health Dentistry, Nair Dental College, Mumbai, India.


*Corresponding Author

Dr. Shrikanth Muralidharan,
Reader, Department of Public Health Dentistry, Madha Dental College and Hospital, West Tambaram, Chennai, India.
Tel: 8308008831
E-mail: Shrikanthmuralidharan23@gmail.com

Received: February 05, 2021; Accepted: October 01, 2021; Published: October 21, 2021

Citation: Shrikanth Muralidharan, Arunkumar Acharya, Pramila M, Shanthi Margabandhu, Seema Kamble. A Review On The Guidelines For Nutritional Assessment for HNC (Head and Neck Cancer) Patients Managed By Surgery. Int J Dentistry Oral Sci. 2021;8(10):4784-4789. doi: dx.doi.org/10.19070/2377-8075-21000970

Copyright: Shrikanth Muralidharan©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.



Abstract

There are a number of guidelines to assess the nutrition status of cancer cases. None of these guidelines are specifically Head and Neck (HNC) cancer related; except for the European guidelines. This paper reviews the different guidelines in nutrition for cancer cases and also their drawbacks.



1.Keywords
2.Introduction
3.Materials and Methods
3.Results
4.Discussion
5.Conclusion
5.References


Keywords

HNC; Cancer; Nutrition; Guidelines.


Introduction

The The 2019 ESPEN (European Society for Clinical Nutrition and Metabolism) guideline guidelines state that “early oral feeding is the preferred mode of nutrition for surgical patients”. It is essential to consider any risk that may arise out of underfeeding during the post-operative recovery period. The report provides certain clinical guidelines which need to be followed especially while handling complicated cases like cancer. One essential recommendation is that of early enteral feeding. Its focus is on the concept of nutritional aspects of the Enhanced Recovery After Surgery (ERAS). The guidelines call for, “integration of nutrition into the overall management of the patient”. Nutritional assessment and dietary recommendations was always a challenge for such cases [1]. Most of the guidelines have been generic in nature and not tailor made for Head and Neck Cancer (HNC) patients. Today newer guidelines are available that can serve to assess the nutritional requirements of HNC. Dieticians are able to estimate and achieve the nutritional requirements for HNC patients through set equations provided for cancer patients.


Guidelines For Nutritional Assessment In Cancer Patients

Nutritional impacts occur due to side effects like taste and smell alterations, dysphagia, malabsorption, depression, anxiety, nausea [2]. Hence Nutritional intervention tends to help the patients gain some weight or at least maintain it and produce better surgical outcomes. Baseline assessment is important.

A number of screening tools are available which have been validated among cancer cases (Table 01) [3]. But these are not specific for HNC patients.

The Subjective global assessment (SGA) assesses nutritional status is based on the features of a history (weight change, dietary intake change, gastrointestinal symptoms that have persisted for greater than 2 weeks, and functional capacity) and physical examination (loss of subcutaneous fat, muscle wasting, ankle/sacral edema and ascites). Features are combined subjectively into an overall or global assessment in which patients are rated as being well nourished, moderately (or suspected of being) malnourished, or severely malnourished [4]. PGSGA combines: nutritional screening , assessment, interventional triage and monitors interventional success. Even though recommended in different guidelines, it is not a very oncology specific tool [4].

‘MUST’ is a five-step screening tool to identify adults, who are malnourished, at risk of malnutrition (undernutrition), or obese. It also includes management guidelines which can be used to develop a care plan [5]. The five steps are-

Step 1- Measurement of height and weight to get a BMI score.
Step 2- % of weight loss (unplanned)
Step 3- Acute disease establishment and score.
Step 4- Addition of scores from 1, 2 and 3 to estimate the overall risk of malnutrition.
Step 5- Use guidelines for management and a care plan development.

A baseline assessment can assist us to identify the risk of deficiency of critical nutrients, help to formulate nutrition plan tailor made for specific individuals and monitor its impact at regular intervals or stages by comparing it with the previous assessment [6]. For those with different stages of treatment, more planning is necessary. It has to be monitored and considered separately. The same assessment may not hold true for all patients [7].

Table 02 shows the nutritional assessment criteria that is recommended currently [3].

A systematic nutritional risk screening (NRS) has to be considered in all patients on hospital admission. An approach of only using the body weight as the lone indicator of malnourishment is ineffective since the epidemic of global obesity is on the rise and also there are other metabolic alterations which take place before appreciable change in the body weight [8].



Table 1. Screening tools in assessment of nutrition status among cancer patients.



Table 2. Nutritional assessment parameters recommended currently.



Table 3. BMR estimation for adult male.



Table 4. BMR estimation for adult female.



Table 5. Practical difficulties in OSCE as an assessment tool.


HNC Surgery and Malnourishment

When there is an inadequate intake orally for more than 14 days, it is associated with a high mortality risk. Cancer patients who have a high nutritional risk must receive nutrition based support for 10 to 14 days before any major surgery [3]. In severe cases when possibility of difficulty in eating will persist for more than 7 days, enteral nutrition is always indicated perioperatively [3]. It is also recommended that in case where the food intake is anticipated to be inadequate for more than 10 days then enteral nutrition is recommended. Gastrostomy insertion is done in case feeding is essential via tube for more than 4 weeks [3]. Post- surgical swallowing problems are quite commonly encountered in HNC cases [9]. Post surgically, HNC cases undergo alterations in the short and long term swallowing pattern which subsequently requires enteral feeding [10]. With a compromised deglutition functioning, maintaining a nutrition balance is a big challenge in such cases [11]. A multicentric study reported that pain and scar in the region of surgery may dissuade the patients from consuming food normally. Those with more than 10 kg of weight loss post surgically were more dependent on mashed food [12]. There was only one study showing positively more cases (60%) who were able to tolerate normal or soft diet and not dependent on tube feeding in less than 2 months of surgery. The authors state that, after a partial mandibulectomy procedure, a good reconstruction and early intervention for obtaining occlusion and normal functioning is the key to avoid nutrition associated complications in such surgeries [13]. So dietary plan should be part of the routine discharge summary and rehabilitative procedure for HNC cases undergoing surgery.


Guidelines For Estimating Nutritional Requirements Among Cancer Patients

An initial method of estimating Basal Metabolic Rate (BMR) for adults was proposed by Schofield in 1985 [14]. The equations are as follows-

The actual energy needed per day (ERR) can be calculated from the BMR after multiplying it by an activity factor as shown in Table 05-

In cancer cases, the Total Energy Expenditure (TEE) is also estimated using the formula-

TEE = Resting Energy Expenditure (REE)+ activity-associated energy expenditure.

The drawback of using this formula is that it is not specific to HNC. REE is elevated in cases of cancer but in advanced cases due to fatigue and reduced physical activities lead to decrease in TEE [15]. Hence neither REE nor TEE can serve as an accurate prediction in HNC. Indirect calorimetric measurements serve as an accurate predictor for REE and is considered for all patients who are at- risk for malnourishment [16].

Another recommended target range to maintain or restore the lean body mass is 25- 30 kcal/kg/day with 1.2 to 1.5 grams of protein/kg/day. In severely depleted cases, higher protein supply may be required [17].

The Glasgow Prognostic Score (GPS), which includes the serum levels of C- reactive proteins as well as albumin, serves as a highly predictable tool for inflammation in cancer patients [18]. This rise in inflammation may be reactionary to the tumour growth and serves as a marker for overall survival of the patients [19]. Rayan and colleagues suggested that a retrospective analysis of the computed tomographic records can also help to detect the muscle mass loss and the fatty muscle infiltration [20].

The latest ESPEN guidelines recommend the following 8-

1. Screen each patient's nutritional status early in the course of cancer treatment.
2. Identify signs or symptoms of anorexia, cachexia, and sarcopenia at the earliest.
3. Use of CT scan for detecting sarcopenia.
4. Use of specific biomarkers like CRP and albumin to assess cancer related systemic inflammation, e.g. CRP and albumin.
5. Use indirect calorimetry to estimate REE to personalize protein and energy needs.
6. Use nutrition and metabolic support as a vital part of cancer care.
7. Assess physical function routinely to monitor and guide physical rehabilitation.

Even though multiple methods have been suggested, these methods of estimation of nutrition are not very specific to the HNC cases. Hence a common consensus regarding their utilization in day-to-day practise is missing in literature.

Cancer and its treatment approaches therefore affect the nutritional status by altering the metabolic function and reduced food intake. Dietary supplements and fortified foods are used by patients as an adjunct to standard treatment. Evidence for international guidelines specifically for the type of HNC is missing.

Hence one size fits all may not be true for such cases. Hence a common guideline, specifically for HNC cases separately is essential to assist the dieticians in formulation of diet counselling sessions and advisories in HNC patients.

Thus reduced nutritional status can be seen from the initial diagnosis which may exacerbate due to treatment related toxicities. Complications arising out of this may persist for a longer duration. Hence assessment of the nutritional status must be a part of the routine monitoring process for HNC patients. An early intervention can help to minimize the co morbidities associated with HNC treatment [21]. The European recommendations are the only set of guidelines that focus on HNC patients. Even though other guidelines are there, they are more general and not pertaining to a particular system affected or the specific therapy for cancer.

HNC patients are different from the other cancer types, due to the complex nature of the systems involved. Major chances of complications (local and systemic) can arise post HNC surgery like scar, pain, delayed wound healing, localized infection. Nutrition assessment of these patients is essential part of a multi-disciplinary approach to treatment. A failure of such an assessment can increase the complications and increase mortality rates. This assessment forms a part of pre as well as post-surgical period. Studies have reported quite contrasting outcomes with respect to the assessment techniques as well as the routes feeding. Different schools of thoughts can result in a neglected role of dietician in cancer therapy and also delay the physical as well as psychological healing of the patients; and also their quality of life, where diet is an important component. The recent ESPEN guidelines have been proposed for assessment for HNC cases, very little evidence is present on the feasibility of these guidelines to be used as an integral part of day to day practise.

Prior to the 2019 guidelines, specific assessment cut offs were not available for HNC patients undergoing any form of therapy. The assessment criteria were more generic than specific.At an institutional level, the ESPEN guidelines can serve to propose a better assessment of HNC patients and aid in more subjective and uniform evaluation of the nutritional intervention therapy.

Clinically the loss of weight or a low BMI usually indicate cachexia/ anorexia clinically [2]. Weight changes are not always associated with nutrition intake alone. BMI does account for the fluid loss like in dehydration or for a loss of body mass that makes a patient extremely lean [22]. Since BMI does not take into account the body composition, it at times can be misleading and false negative results may be generated [23]. There is always a possibility that cancer patients may present with normal body weight but sarcopenia may be severe in them. (I did not find any specific tool apart from BMI that was used for sarcopenia) So BMI cannot always be regarded as a lone gold standard for assessment sake 24. Serum albumin levels are changed in cancer cases; but these indicate the severity of any underlying inflammation rather than the severity of the disease itself. Their levels may not always be altered in all cancer cases due to the disease condition or the therapy provided alone [25]. The initial problem is that there is a complete lack of epidemiological data in terms of malnutrition related to HNC cancer [26]. Hence one does not always know the exact severity of the prevalence of malnutrition among HNC patients. The newer guidelines are an attempt to overcome this hurdle. There is a lack of uniform assessment pattern across the different hospitals curtailing to the needs of HNC patients; which was always a challenge. Taking an overall anthropometric measurement for all cases may not be feasible and is time consuming in the ward. Hence a total assessment of the body composition is also missed during the routine clinical examinations for HNC patients [27]. One size fits all rule also cannot be followed in HNC cases due to the complexity of the anatomical structures involved and also the different types of cancer and the combination of therapeutic options used for treatment purposes.

The PENG 2019 guidelines estimates the nutritional requi
rements for the cancer patients overall, but whether it is true for all those patients with different therapeutic interventions is yet not evident.A recent study reported that just meeting the minimum requirements as per the ESPEN guidelines may not attenuate loss of skeletal muscle in HNC patients [28]. The severity of the cancer, type of surgery and the post-surgical interventions should also be considered while the nutritional assessment is being done. End stage patients may need more interventions comparatively. Nutritional assessment should be therefore more holistic and not focus only on achieving a particular cut- off criteria. The nutritional assessment should also be part of the routine home based care.

In order to establish an accurate REE for patients, it is essential to understand the actual energy requirements by the patients. Only this can provide a better insight into an actual maintenance and overcome complications arising due to inadequate nutrition supply. This REE which is usually higher in cancer cases (more than 70%) is influenced by a variety of factors such as age of the patients, gender, fat free mass and the total body mass [25]. An increase in the physical activity of the patients can further increase REE. So the calculations have to be custom made again per patient. One can measure the REE by using the Harris–Benedict equation(HB) or the indirect calorimetry (IC). A study by Gracia- Peris and colleagues reported that using HB for BMR calculation is not always accurate in chemotherapy patients as compared to IC. So they suggest that IC is a gold standard technique than the HB equation [29]. In surgical cases of HNC, there are no literature reports if HB is a valid formula for estimation of BMR. Hence more studies are needed for stronger evidence. In case of advanced surgery, recovery phases may be prolonged along with the duration of hospital stay, testing the newer PENG guidelines for such cases is essential. Variability with respect to nutritional requirement and also the response to the nutritional therapy can be expected in relation to the type of tumour, surgical technique and also the age and gender of the patients. The nutritional assessment as per the new PENG guidelinesmay be different for cases which undergo chemo and radiotherapy also apart from surgery. Hence more evidence is required for case-based utilization of the guidelines. Different equations for assessment and cut off criteria may be required for cases which undergo only surgery and for cases which may require surgery and chemoradiotherapy. BMI is the mainly used indicator for weight loss and indirectly correlates to malnourishment, using the same cut-off range for the non- cancer patients may require further review. All patients with cancer undergo alteration in the BMI. Hence a basic criterion for BMI classification for cancer patients and especially HNC cases is highly recommended. Therefore a patient, who already had a low BMI at the baseline, is more likely have low BMI score postsurgery. So the nutritional requirements should consider such a scenario while determining the outcomes.

Using the same assessment method for different categories of cancer is questionable. More evidence is needed for determining the sensitivity and specificity of the tool. If the newer guidelines are being used for estimation, then the chart for entries needs to be redrawn with a proper training and appraisal regarding the need to do so. The guidelines do not state any separate method for cases which need increased length of the hospital stay. Under such circumstances, a prolonged stay may be associated with better nutritional outcomes rather than home based care 30.Some of the equations previously used for nutritional assessments were generated by estimating the requirements in adult young participants. Hence this needs to be validated for its use in older individuals also.


Recommendations

1. Maintenance of food records is essential. Oncologists or nursing staffs may alter the food intake (quantity, nature) based on the request and condition of the patient. Example- a case undergoing glossectomy may need pureed food, since chewing and swallowing is a major challenge. So such specifications must be put on paper and additional help must be sought for the long term benefit of the patients.

2. The current guidelines do not take into account the different classes of BMI. But cancer specific cut offs for BMI are required with respect to BMI since it is a major part of the assessment criteria.

3. It is recommended to have a robust study with an idea case scenario where the sample size is large enough for statistically significant data. Also it needs to involve people with different races, have both male and female patients, and the cases matched for the type of cancer categorization. Performing an actual nutritional intervention using blinding can provide stronger evidence. This can help to provide more information about the assessment criteria specific for age, gender and also the type of cancer.

4. It may be ideal to have followed up of the cases to determine the weight gain, change in the body mass (from lean to healthy), REE and protein intake.


References

    [1]. Shetty S, Kattappagari KK, Hallikeri K, Krishnapilli R. Evaluation of oral lesions in HIV seropositive individuals and its correlation with CD4+ Tlymphocytic count. Journal of Dr. NTR University of Health Sciences. 2016 Apr 1;5(2):123.
    [2]. Chaurasia A. CD4+ counts and Oral Lesions in HIV infected/AIDS patientsan Indian Perspective. Juniper online Journal of Case Study. 2017;1(5):1-2.
    [3]. Denny CE, Ramapuram J, Bastian TS, Ongole R, Binnal A, Natarajan S. Oral lesions in HIV/AIDS patients on highly active antiretroviral therapy. World Journal of Dentistry. 2016 Apr 1;7(2):95-9.
    [4]. Arirachakaran P, Hanvanich M, Kuysakorn P, Thongprasom K. Antiretroviral Drug-Associated Oral Lichenoid Reaction in HIV Patient: A Case Report. Int J Dent. 2010;2010:291072. Pubmed PMID: 20671969.
    [5]. Heron SE, Elahi S. HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation. Front Immunol. 2017 Mar 7;8:241. Pubmed PMID: 28326084.
    [6]. Leao JC, Ribeiro CM, Carvalho AA, Frezzini C, Porter S. Oral complications of HIV disease. Clinics (Sao Paulo). 2009 May;64(5):459-70. Pubmed PMID: 19488613.
    [7]. Jayakaran TG. The effect of drugs in the oral cavity-A review. Journal of pharmaceutical sciences and research. 2014 Feb 1;6(2):89.
    [8]. Max B, Sherer R. Management of the adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis. 2000 Jun;30 Suppl 2:S96-116. Pubmed PMID: 10860894.
    [9]. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med. 2004 Jul 1;15(4):221-39. Pubmed PMID: 15284187.
    [10]. Shrivastava S, Ts B, Singh A, Singh S. ADVERSE EFFECTS OF ANTIRETROVIRAL THERAPY ON ORAL TISSUES IN HIV POSITIVE INDIVIDUALS. Oral & Maxillofacial Pathology Journal. 2013 Jan 1;4(1).
    [11]. Yuan A, Woo SB. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jan;119(1):35-47. Pubmed PMID: 25442252.
    [12]. Krishna AB, Gannepalli A, Baghirath PV, Khaled S, Shailaja S, Anuradha C. Age-related - oral manifestations and co-morbidities in human immunodeficiency virus-infected/acquired immune deficiency syndrome adults in Hyderabad, India. Indian J Dent Res. 2015 Jul-Aug;26(4):351-5. Pubmed PMID: 26481879.
    [13]. Chakraborty N, Mukherjee A, Santra S, Sarkar RN, Banerjee D, Guha SK, et al. Current trends of opportunistic infections among HIV-seropositive patients from Eastern India. Jpn J Infect Dis. 2008 Jan;61(1):49-53. Pubmed PMID: 18219134.
    [14]. Saha K, Firdaus R, Santra P, Pal J, Roy A, Bhattacharya MK, et al. Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata. Virol J. 2011 Mar 14;8:116. Pubmed PMID: 21396133. [15]. Kumar S, Gowda S, Basavarajaiah. Incidence of Oral candidiasis among HIV infected. Int J Sci Res Publ. 2013;3(12):1-6.
    [16]. Muralidharan S, Acharya AK, Margabandhu S, Kalekhan S, Ahsan S, Kulkarni D. Prevalence of Periodontitis and Soft Tissue Lesions among Human Immunodeficiency Virus-positive Patients on Antiretroviral Therapy in Raichur Taluk, Karnataka, India. J Contemp Dent Pract. 2018 Jan 1;19(1):42-46. Pubmed PMID: 29358533.
    [17]. Panda S, Kamei G, Pamei M, Sarkar S, Sarkar K, Singh ND, et al. Clinical features of HIV infection in drug users of Manipur. Natl Med J India. 1994 Nov-Dec;7(6):267-9. Pubmed PMID: 7841877.
    [18]. Shrimali Lalit. A Study Of Oral Manifestation Of HIV / AIDS. Int J Oral Maxillofac Pathol. 2010;1:8-12.
    [19]. Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci. 2011 Jun;53(2):203- 11. Pubmed PMID: 21712625.
    [20]. Hegde MN, Hegde ND, Malhotra A. Prevalence of oral lesions in HIV infected adult population of Mangalore, Karnataka, India. Biodiscovery. 2012 Oct 23;4:e8935.
    [21]. Rao UK, Ranganathan K, Kumarasamy N. Gender differences in oral lesions among persons with HIV disease in Southern India. J Oral Maxillofac Pathol. 2012 Sep;16(3):388-94. Pubmed PMID: 23248472.
    [22]. Annapurna CS, Prince CN, Sivaraj S, Ali IM. Oral manifestations of HIV patients in South Indian population. J Pharm Bioallied Sci. 2012 Aug;4(Suppl 2):S364-8. Pubmed PMID: 23066291.
    [23]. Jindwani K, Singh K, Dadlani H. A study of oral lesions among HIV positives in a tertiary care hospital.
    [24]. Kumar S, Mishra P, Warhekar S, Airen B, Jain D, Godha S. Oral Health Status and Oromucosal Lesions in Patients Living with HIV/AIDS in India: A Comparative Study. AIDS Res Treat. 2014;2014:480247. Pubmed PMID: 25215229.
    [25]. Sanadhya YK, Sanadhya S, Nagarajappa R, Jain S, Aapaliya P, Sharma N. Correlation between oral lesions and opportunistic infections among human immunodeficiency virus - infected individuals in Indian population. Int Marit Health. 2014;65(3):124-30. Pubmed PMID: 25471161.
    [26]. Ravi JR, Rao TR. Estimation of prevalence of periodontal disease and oral lesions and their relation to CD4 counts in HIV seropositive patients on antiretroviral therapy regimen reporting at District General Hospital, Raichur. J Indian Soc Periodontol. 2015 Jul-Aug;19(4):435-9. Pubmed PMID: 26392694.
    [27]. Patil N, Chaurasia VR, Babaji P, Ramesh D, Jhamb K, Sharma AM. The effect of highly active antiretroviral therapy on the prevalence of oral manifestation in human immunodeficiency virus-infected patients in Karnataka, India. Eur J Dent. 2015 Jan-Mar;9(1):47-52. Pubmed PMID: 25713484.
    [28]. Hegde V, Shetty PJ, Alva S, Chengappa SK. Assessment of dental caries experience, periodontal status, and oral mucosal lesions among human immunodeficiency virus seropositives with and without antiretroviral therapy: A cross-sectional study. Journal of Indian Association of Public Health Dentistry. 2016 Jan 1;14(1):46.
    [29]. Usha H, Naik B. Comparison of oral lesions in HIV patients with and without highly active antiretroviral therapy visiting government hospitals in Bengaluru city. J Evid Based Med Healthc. 2017;4(20):1141-1147.
    [30]. Dongade S, Sermadi ZM, Manjunath R, Priyadarshini C, Jayapala MS. Prevalence of oral manifestations among hiv-positive patients undergoing antiretroviral treatment visiting Chamarajanagar district hospital: A crosssectional study. Journal of Indian Academy of Oral Medicine and Radiology. 2017 Oct 1;29(4):288.

         Indexed in

pubhub  CGS  indexcoop  
j-gate  DOAJ  Google_Scholar_logo

       Total Visitors

SciDoc Counter

Get in Touch

SciDoc Publishers
16192 Coastal Highway
Lewes, Delaware 19958
Tel :+1-(302)-703-1005
Fax :+1-(302)-351-7355
Email: contact.scidoc@scidoc.org


porn